ABMD Stock - Abiomed Inc.

ABMD Stock Chart

ABMD Profile

Abiomed Inc. (ABMD) is a medical technology company that develops, manufactures, and markets medical devices for circulatory support and heart recovery. The company's flagship product, the Impella heart pump, is a minimally invasive device used to provide temporary circulatory support to patients with acute heart failure or undergoing certain high-risk coronary procedures.

As of its last market close, ABMD had a market capitalization of approximately $14.8 billion USD. The company had a trailing twelve-month revenue of approximately $905 million USD and a net income of approximately $170 million USD. ABMD's stock price had a 52-week range of $187.22 - $387.78 USD and was trading at approximately $238.35 USD at the time of its last market close.

Abiomed is focused on expanding the adoption of its Impella heart pump in the United States and internationally. The company is also developing new products and applications for its circulatory support technology.

Investing in ABMD carries risks, including risks associated with changes in technology and customer preferences, as well as risks associated with competition and market conditions. Additionally, Abiomed is subject to regulatory and geopolitical risks, which could impact its financial performance. Investors should carefully consider these risks before making any investment decisions.

ABMD Revenue Chart

ABMD Earnings

Analyst Ratings